Windtree Therapeutics

WINT · NASDAQ

$0.001+$0.00 (+0.00%)TodayMarket closed ·
Prev close $0.001

Latest news

  • Press releasePRNewswire

    TransCode Therapeutics Announces Leadership Transition

  • Press releaseGlobe Newswire

    Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates

  • Press releaseGlobe Newswire

    Windtree Therapeutics Announces It May Receive License Agreement Payments from Its Licensee for Renewed Acute Pulmonary Development by the Licensee

  • Press releaseGlobe Newswire

    Windtree Therapeutics Announces More Strengthening of Its Istaroxime and Next Generation SERCA2a activator Patent Estate

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • Press releaseGlobe Newswire

    Windtree Therapeutics Announces Large Reduction of Preferred Series C and D Shares Outstanding by Conversion and Redemption

  • NewsMurtuza J Merchant

    Why Are Public Companies Amassing ETH, XRP, SOL, BNB Instead Of Just Bitcoin?

  • Press releaseGlobe Newswire

    Windtree Therapeutics Announces Up To $520 Million in New Funding to Amplify BNB Cryptocurrency Treasury Strategy

  • Press releaseGlobe Newswire

    Kraken and Windtree Therapeutics Announce Strategic Partnership for BNB Custody, Trading, and OTC Services

  • NewsAvi Kapoor

    Dow Jumps Over 100 Points; PepsiCo Posts Upbeat Earnings

  • Press releaseGlobe Newswire

    Windtree To Launch BNB Crypto Treasury Strategy With Agreement For $60 Million Investment Led By Build And Build Corp. With Up To $140 Million More In Follow On Subscriptions

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • Press releaseGlobe Newswire

    Windtree Announces Issuance of Istaroxime Patent for the United States for Acute Heart Failure

  • Press releaseGlobe Newswire

    Windtree Announces Istaroxime Phase 2 Cardiogenic Shock Study Hits Enrollment Target for Planned Interim Analysis

  • NewsAdam Eckert

    Windtree Therapeutics Stock Is Volatile This Week: What's Going On?

  • NewsDylan Berman

    Windtree Stock Is Rising Tuesday: What's Going On?

  • Press releaseBusiness Wire

    Evofem Biosciences' CEO Saundra Pelletier Joins Aditxt Board of Directors

  • News

    12 Health Care Stocks Moving In Tuesday's After-Market Session

  • News

    Windtree Therapeutics Q4 EPS $(4.63) Beats $(28.82) Estimate

  • Press releaseGlobe Newswire

    Windtree Therapeutics Reports First Quarter 2025 Financial Results and Provides Key Business Updates

  • Press releasePRNewswire

    Evofem Expects Significant Reduction in PHEXXI Manufacturing Cost Through Agreement with Windtree Therapeutics

  • NewsRishabh Mishra

    US Stocks Likely To Open Lower After 3-Day Advance: Market Is Looking 'More Balanced' And Gone From 'Above-Trend To On-Trend,' Says Expert

  • Press releasePRNewswire

    Evofem Reports Fourth Consecutive Year of Net Sales Growth

  • News

    12 Health Care Stocks Moving In Friday's Intraday Session

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • NewsAvi Kapoor

    Crude Oil Gains Over 1%; US Weekly Jobless Claims Increase

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • NewsVandana Singh

    Windtree Therapeutics Heart Failure Drug Candidate Improves Systolic Blood Pressure

  • NewsAvi Kapoor

    Why Intuitive Machines Shares Are Trading Higher By Around 41%; Here Are 20 Stocks Moving Premarket

  • NewsHenry Khederian

    Why Windtree Therapeutics (WINT) Stock Is Volatile Today

  • NewsAvi Kapoor

    S&P 500 Gains Over 1%; 3M Shares Jump After Q2 Results

  • NewsAvi Kapoor

    Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session

  • NewsAvi Kapoor

    Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results

  • NewsAvi Kapoor

    Dow Surges 550 Points; Headline PCE Price Index Falls To 2.5%

  • NewsErica Kollmann

    What's Going On With Windtree Therapeutics Stock?

  • News

    Market-Moving News for July 26th

  • NewsAvi Kapoor

    Why Ultra Clean Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.